ClearPoint Neuro, Inc.
CLPT
$12.97
-$0.14-1.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.84% | 8.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.84% | 8.60% | |||
| Cost of Revenue | -10.88% | 9.13% | |||
| Gross Profit | 0.79% | 8.26% | |||
| SG&A Expenses | 0.23% | -6.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.09% | 1.69% | |||
| Operating Income | 7.11% | 7.84% | |||
| Income Before Tax | -1.22% | 3.26% | |||
| Income Tax Expenses | -68.00% | 38.89% | |||
| Earnings from Continuing Operations | -0.93% | 3.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.93% | 3.14% | |||
| EBIT | 7.11% | 7.84% | |||
| EBITDA | 1.40% | 12.81% | |||
| EPS Basic | -0.29% | 4.97% | |||
| Normalized Basic EPS | -0.62% | 5.17% | |||
| EPS Diluted | -0.29% | 4.97% | |||
| Normalized Diluted EPS | -0.62% | 5.17% | |||
| Average Basic Shares Outstanding | 0.60% | 1.95% | |||
| Average Diluted Shares Outstanding | 0.60% | 1.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||